VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10037070 | HBV | ENSG00000105143.13 | protein_coding | SLC1A6 | No | No | 6511 | P48664 |
TVIS30081872 | HIV | ENSG00000105143.13 | protein_coding | SLC1A6 | No | No | 6511 | P48664 |
TVIS30086713 | HIV | ENSG00000105143.13 | protein_coding | SLC1A6 | No | No | 6511 | P48664 |
TVIS20053956 | HPV | ENSG00000105143.13 | protein_coding | SLC1A6 | No | No | 6511 | P48664 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | SLC1A6 |
---|---|
DrugBank ID | DB00142 |
Drug Name | Glutamic acid |
Target ID | BE0002270 |
UniProt ID | P48664 |
Regulation Type | |
PubMed IDs | 17139284; 17016423; 9224806; 9838098 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Gegelashvili G, Schousboe A: High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol. 1997 Jul;52(1):6-15.@@Lin CL, Tzingounis AV, Jin L, Furuta A, Kavanaugh MP, Rothstein JD: Molecular cloning and expression of the rat EAAT4 glutamate transporter subtype. Brain Res Mol Brain Res. 1998 Dec 10;63(1):174-9. |
Groups | Approved; Nutraceutical |
Direct Classification | Glutamic acid and derivatives |
SMILES | N[C@@H](CCC(O)=O)C(O)=O |
Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
PharmGKB | PA449776 |
ChEMBL | CHEMBL575060 |